Genfit S.A (GNFT) | Stock Overview & Key Data

What is GNFT's 52-week high and low?

In the last 52 weeks, Genfit S.A reached a high of €5.86 (on October 17, 2024) and a low of €2.62 (on April 7, 2025).

What is the market cap and P/E ratio for GNFT?

Curious about Genfit S.A's size and valuation? Its market capitalization stands at 167.59M. When it comes to valuation, the P/E ratio (trailing twelve months) is 111.73, and the forward P/E (looking ahead) is 17.79.

Does GNFT pay dividends? If so, what's the yield?

As for dividends, Genfit S.A isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Genfit S.A's main competitors or similar companies to consider before investing?

When looking at Genfit S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Medincell S.A MEDCL	565.47M	Healthcare	Biotechnology	14.09%	250.10%
Valneva SE VLA	409.51M	Healthcare	Biotechnology	-22.50%	-76.15%
BNP Paribas Easy BLUE	456.71M	Healthcare	Biotechnology	-1.80%	10.23%
Abivax SA ABVX	331.73M	Healthcare	Biotechnology	-43.58%	-25.92%
Inventiva S.A IVA	379.00M	Healthcare	Biotechnology	-5.42%	-55.14%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Genfit S.A.? (e.g., ROE, Debt/Equity)

To get a sense of Genfit S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 2.20%, the Debt to Equity ratio from the most recent quarter is 89.76, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for GNFT?

Looking at Genfit S.A's growth, its revenue over the trailing twelve months (TTM) was €71M. Compared to the same quarter last year (YoY), quarterly revenue grew by -50.50%, and quarterly earnings saw a YoY growth of N/A.

How much of GNFT stock is held by insiders and institutions?

Wondering who owns Genfit S.A stock? Company insiders (like executives and directors) hold about 13.23% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.93%.

For more common questions about our data, please visit our About Data page.